Search PubMed⌕ Search

PubMed · 12940723

Dendrimer disassembly by benzyl ether depolymerization.

Abstract

The disassembly of dendritic structures was realized by a cascade cleavage reaction triggered by an initially stimulated group in the dendrimer periphery. A depolymerizable backbone was engineered into prototypical dendritic structures. Evidence for the completion of the disassembly process is provided by the absorbance peak of the p-nitrophenoxide ion that was intentionally installed at the focal point of the dendrons. Observation of the UV spectra during the disassembly process supports a stepwise cascade cleavage proceeding from the periphery into the core.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Sheng Li, Michael L Szalai, Robert M Kevwitch, Dominic V McGrath. 2003-09-03. Dendrimer disassembly by benzyl ether depolymerization.. https://doi.org/10.1021/ja0349960

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Application of artificial neural networks in the design of controlled release drug delivery systems.

Controlled release drug delivery systems offer great advantages over the conventional dosage forms. However, there are great challenges to efficiently develop controlled release drug delivery systems due to the complexity of these delivery systems. Traditional statistic response surface methodology (RSM) is one of the techniques that has been employed to develop and formulate controlled release dosage forms. However, there are some limitations to the RSM technique. Hence, another technique called artificial neural networks (ANN) has recently gained wide popularity in the development of controlled release dosage forms. In this review, the basic ANN structure, the development of the ANN model and an explanation of how to use ANN to design and develop controlled release drug delivery systems are discussed. In addition, the applications of ANN in the design and development of controlled release dosage forms are also summarized in this review.

Delayed-Action Preparations↗

Organosilicate-polymer drug delivery systems: controlled release and enhanced mechanical properties.

Dexamethasone-loaded poly(ethylene-co-vinyl acetate) (EVAc) nanocomposites were fabricated via solution-casting with three different organosilicates for study in a drug delivery system. X-ray diffraction (XRD) showed that all three nanocomposites were in an intercalated morphology. Release studies of dexamethasone into phosphate-buffered saline revealed that the presence of silicates reduced the rate of drug release, and this reduction was a function of volume fraction of silicate in the composite, as well as the aspect ratio of the silicate layers. It was also found that the presence of silicate in a nanocomposite resulted in an increase in the Young's modulus as compared to the pure polymer, and this increase was also a function of the volume fraction of silicate present as well as the aspect ratio of the silicate layers. Silicates are a viable additive to EVAc drug delivery systems, providing controlled release characteristics as well as enhanced mechanical properties in an economically and biologically safe manner.

Delayed-Action Preparations↗